Literature DB >> 25749645

Digoxin use in atrial fibrillation: a critical reappraisal.

Sadiya S Khan1, Mihai Gheorghiade2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25749645     DOI： 10.1016/S0140-6736(14)62301-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Beta-blockers or Digoxin for Atrial Fibrillation and Heart Failure?

Authors:  Laurent Fauchier; Guillaume Laborie; Nicolas Clementy; Dominique Babuty
Journal:  Card Fail Rev       Date:  2016-05

2.  Prevalent digoxin use and subsequent risk of death or hospitalization in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) randomized controlled trial.

Authors:  Andrew P Ambrosy; Ankeet S Bhatt; Amanda L Stebbins; Lisa M Wruck; Marat Fudim; Stephen J Greene; William E Kraus; Christopher M O'Connor; Ileana L Piña; David J Whellan; Robert J Mentz
Journal:  Am Heart J       Date:  2018-02-11       Impact factor: 4.749

3.  Relationship between HRV measurements and demographic and clinical variables in a population of patients with atrial fibrillation.

Authors:  Carmelo Buttà; Antonino Tuttolomondo; Alessandra Casuccio; Rossella Petrantoni; Giuseppe Miceli; Francesco Cuttitta; Antonio Pinto
Journal:  Heart Vessels       Date:  2016-03-03       Impact factor: 2.037

4.  Assumption versus evidence: the case of digoxin in atrial fibrillation and heart failure.

Authors:  Udo Bavendiek; Lukas Aguirre Davila; Armin Koch; Johann Bauersachs
Journal:  Eur Heart J       Date:  2017-07-14       Impact factor: 29.983

5.  Increased All-Cause Mortality Associated With Digoxin Therapy in Patients With Atrial Fibrillation: An Updated Meta-Analysis.

Authors:  Ying Chen; Xiaoyan Cai; Weijun Huang; Yanxian Wu; Yuli Huang; Yunzhao Hu
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

6.  Chronic digitalis therapy in patients before heart transplantation is an independent risk factor for increased posttransplant mortality.

Authors:  Rasmus Rivinius; Matthias Helmschrott; Arjang Ruhparwar; Ann-Kathrin Rahm; Fabrice F Darche; Dierk Thomas; Tom Bruckner; Philipp Ehlermann; Hugo A Katus; Andreas O Doesch
Journal:  Ther Clin Risk Manag       Date:  2017-10-13       Impact factor: 2.423
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.